CardioNet Inc. (BEAT) Drops 5.17% on January 28

Equities Staff |

CardioNet Inc. (BEAT) was one of the Russell 2000's biggest losers for Thursday January 28 as the stock slid 5.17% to $10.09, a loss of $-0.55 per share. Starting at an opening price of $10.67 a share, the stock traded between $9.91 and $10.83 over the course of the trading day. Volume was 174,128 shares over 1,326 trades, against an average daily volume of 283,929 shares and a total float of 27.26 million.

The losses send CardioNet Inc. down to a market cap of $275.06 million. In the last year, CardioNet Inc. has traded between $16.96 and $7.86, and its 50-day SMA is currently $11.72 and 200-day SMA is $11.58.

The stock has a P/E Ratio of 108.7.

BioTelemetry Inc provides cardiac monitoring services, cardiac monitoring device manufacturing, and centralized cardiac core laboratory services. It operates & provides patient Services, products and research services.

CardioNet Inc. is based out of Malvern, PA and has some 922 employees. Its CEO is Joseph H. Capper.

For a complete fundamental analysis analysis of CardioNet Inc., check out’s Stock Valuation Analysis report for BEAT. To see the latest independent stock recommendations from’s analysts, visit our Research section.

The Russell 2000 is one of the leading indices tracking small-cap companies in the United States. It's maintained by Russell Investments, an industry leader in creating and maintaining indices, and consists of the smallest 2000 stocks from the broader Russell 3000 index.

Russell's indices differ from traditional indices like the Dow Jones Industrial Average (DJIA) or S&P 500, whose members are selected by committee, because they base membership entirely on an objective, rules based methodology. The 3,000 largest companies by market cap make up the Russell 3000, with the 2,000 smaller companies making up the Russell 2000. It's a simple approach that gives a broad, unbiased look at the small-cap market as a whole.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Breathtec BioMedical Inc.

Breathtec Biomedical Inc is a medical diagnostics company. It is engaged in developing & commercializing breath analysis devices for the early detection of infections & life threatening diseases including cancers,…

Private Markets


The spark hit Jamie when he saw co-workers competing to lose weight. Instead of pizzas and subs, they were eating salads and jogging along the river. Some were sneakily leaving…

Initial State

Initial State is an Internet of Things (IoT) data analytics & data management platform company. We turn sensor and event data into information that matters by making it easy to…